MDL No. 2809 created for Onglyza Lawsuits
MDL No. 2809 created for Onglyza Lawsuits
Introduction
Finally, the U.S. Judicial Panel on Multidistrict Litigation gave a nod for centralization of all the federally-filed Onglyza and Kombiglyze XR lawsuits in a single U.S. District Court, Eastern District of Kentucky on 2nd February for the purpose of coordinated pretrial proceedings. The resulting MDL: 2809-In Re: Onglyza and Kombiglyze XR Products Liability Litigation is to be presided by Honorable Judge Karen K. Caldwell.
The court records show more than 80 product liability lawsuits are pending in the federal court system filed by individuals who developed congestive heart failure and other side effects accusing Bristol-Myers Squibb and AstraZeneca as the defendants.
More cases are expected to be added to this litigation as plaintiffs continue filing cases nationwide, who feel they developed heart failure or other health problems due to the lack of adequate warnings on the diabetes drug.
Comments
Latest News
Teen E-cigarette Use Hits 10-Year Low
Categories: E-Cigarette: JUUL
Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…
Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m
Categories: Opioids
The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…
Drug Distributors Reach $300M Opioid Settlement
Categories: Opioids
The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…